Failure of a Non-Authorized Copy Product to Maintain Response Achieved With Imatinib in a Patient With Chronic Phase Chronic Myeloid Leukemia: A Case Report

Journal of Medical Case Reports - United Kingdom
doi 10.1186/1752-1947-3-7112
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Leukemia Cutis in a Patient With Chronic Myeloid Leukemia

IOSR Journal of Dental and Medical Sciences
2014English

Successful Delivery After Planned Discontinuation of Imatinib in a Patient With Chronic Myeloid Leukemia

Internal Medicine
Internal MedicineMedicine
2009English

Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia

Haematologica
Hematology
2010English

Polycomb Genes Are Associated With Response to Imatinib in Chronic Myeloid Leukemia

Epigenomics
Cancer ResearchGenetics
2015English

Imatinib Failure and Response to Dasatinib in a Patient With Chronic Myeloid Leukemia in Blast Crisis and a Novel, Nine-Nucleotide BCR-ABL Insertion Mutation

Blood Cancer Journal
OncologyHematology
2013English

Development of Multiple Myeloma in a Patient With Chronic Myeloid Leukemia After Treatment With Imatinib Mesylate

Oncologist
Cancer ResearchMedicineOncology
2005English

Imatinib Pharmacokinetics and Its Correlation With Response and Safety in Chronic-Phase Chronic Myeloid Leukemia: A Subanalysis of the IRIS Study

Blood
BiochemistryImmunologyCell BiologyHematology
2008English

Therapy - Related Myeloid Neoplasm in a Patient With Prior Treatment for Chronic Lymphocytic Leukemia: A Case Report

Journal of Hematology & Thromboembolic Diseases
2017English

Сase Report of Acute Toxic Imatinib-Induced Hepatitis in a Patient With Chronic Myeloid Leukemia, Sulfa Allergy, and Rheumatoid Arthritis

Cureus
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy